Researchers at WashU Medicine have identified a possible route to tame inflammation in myeloproliferative neoplasms — a group of chronic blood cancers — that could serve as a novel approach to treatment. The study is led by Stephen Oh, MD, PhD, a professor of medicine who treats these patients at Siteman Cancer Center, based at Barnes-Jewish Hospital and WashU Medicine.
Promising target identified against chronic blood cancer
View Content